stockrow
Friday 6 November 2026
Export SOLV’s income statement to Excel — free account
Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.
- Revenue
- −7.01%
- EPS
- −101.0%
- Free cash flow
- +561.9%
- Total debt
- −90.1%
Quarter to September 2026, against a year earlier
90.48
3.30
+3.79%
Follow SOLV
Alert me
Solventum Corporation (SOLV) Revenue growth
Solventum Corporation's revenue growth over the twelve months to 30 September 2026 was −2.84%, down 3.7 percentage points from fiscal 2025 (0.86%). That is below the Medical Instruments & Supplies industry median of 8.97% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 0.86% | 0.16 |
| FY2024 | 0.70% | (0.12) |
| FY2023 | 0.82% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | −7.01% | (9.23) |
| Jun 2026 | 2.22% | 5.26 |
| Mar 2026 | −3.04% | 0.67 |
| Dec 2025 | −3.71% | (4.38) |
| 7 more quarters | Free account |
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| RGEN Repligen Corporation compare | 13.8% |
| WST West Pharmaceutical Services, Inc. compare | 12.6% |
| ATR AptarGroup, Inc. compare | 8.97% |
| BLCO Bausch + Lomb Corporation compare | 8.88% |
| BAX Baxter International Inc. compare | 5.33% |
| COO The Cooper Companies, Inc. compare | 4.73% |
| ALGN Align Technology, Inc. compare | 4.42% |
| AVTR Avantor, Inc. compare | 0.92% |
| SOLV Solventum Corporation | −2.84% |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement